{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T22:55:32Z","timestamp":1768690532324,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T00:00:00Z","timestamp":1542240000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Netw Model Anal Health Inform Bioinforma"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s13721-018-0179-8","type":"journal-article","created":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T02:35:49Z","timestamp":1542249349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Computational study of curcumin analogues by targeting DNA topoisomerase II: a structure-based drug designing approach"],"prefix":"10.1007","volume":"7","author":[{"given":"Rajesh Kumar","family":"Kesharwani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dev Bukhsh","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Durg Vijay","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishna","family":"Misra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,15]]},"reference":[{"key":"179_CR39","unstructured":"ACD\/ChemSketch version 8.0 (2006) Advanced Chemistry Development, Inc., Toronto ON, canada, http:\/\/www.acdlabs.com . Accessed 5 July 2014"},{"issue":"1A","key":"179_CR1","first-page":"363","volume":"23","author":"BB Aggarwal","year":"2003","unstructured":"Aggarwal BB, Kumar A, Bharti AC (2003) Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23(1A):363\u2013398","journal-title":"Anticancer Res"},{"key":"179_CR2","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The protein data bank. Nucleic Acids Res 28:235\u2013242","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"179_CR3","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1182\/blood-2002-05-1320","volume":"101","author":"AC Bharti","year":"2003","unstructured":"Bharti AC, Donato N, Singh S, Aggarwal BB (2003) Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and Ikappa B alpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 101(3):1053\u20131062","journal-title":"Blood"},{"issue":"1","key":"179_CR4","first-page":"87","volume":"948","author":"G Bradley","year":"1988","unstructured":"Bradley G, Juranka PF, Ling V (1988) Mechanism of multidrug resistance. Biochim Biophys Acta 948(1):87\u2013128","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"179_CR5","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1136\/jcp.49.10.848","volume":"49","author":"AR Cattan","year":"1996","unstructured":"Cattan AR, Levett D, Douglas EA, Middleton PG, Taylorm PR (1996) Method for quantifying expression of functionally active topoisomerase II in patients with leukaemia. J Clin Pathol 49(10):848\u2013852","journal-title":"J Clin Pathol"},{"key":"179_CR6","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1124\/mol.106.027714","volume":"70","author":"H Chao-Xin","year":"2006","unstructured":"Chao-Xin H, Zhi-Li Z, Bing X, Jin-Gui M, Mei-Yu G, Li-Ping L, Hua-Liang J, Jian D (2006) Salvicine functions as novel topoisomerase II poison by binding to ATP pocket. Mol Pharmacol 70:1593\u20131601","journal-title":"Mol Pharmacol"},{"key":"179_CR7","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, Sanschagrin PC, Mainz DT (2006) Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem 49:6177\u20136196","journal-title":"J Med Chem"},{"key":"179_CR8","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1021\/ci6005036","volume":"47","author":"PK Gadakar","year":"2007","unstructured":"Gadakar PK, Phukan S, Dattatreya P, Balaji VN (2007) Pose prediction accuracy in docking studies and enrichment of actives in the active site of GSK-3\u03b2. J Chem Inf Model 47:1446\u20131459","journal-title":"J Chem Inf Model"},{"key":"179_CR9","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1021\/ci800324m","volume":"49","author":"T Halgren","year":"2009","unstructured":"Halgren T (2009) Identifying and characterizing binding sites and assessing druggability. J Chem Inf Model 49:377\u2013389","journal-title":"J Chem Inf Model"},{"issue":"1","key":"179_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57\u201370","journal-title":"Cell"},{"issue":"1","key":"179_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S1383-5718(02)00076-1","volume":"518","author":"JM Holy","year":"2002","unstructured":"Holy JM (2002) Curcumin disrupts mitotic spindle structure and induces micronucleation in MCF-7 breast cancer cells. Mutation Res 518(1):71\u201384","journal-title":"Mutation Res"},{"issue":"2","key":"179_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69\u201390","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"179_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2174\/1568009053202081","volume":"5","author":"D Karunagaran","year":"2005","unstructured":"Karunagaran D, Rashmi R, Kumar TR (2005) Induction of apoptosis by curcumin and its implications for cancer therapy. Curr Cancer Drug Targets 5(2):117\u2013129","journal-title":"Curr Cancer Drug Targets"},{"issue":"1","key":"179_CR14","first-page":"106","volume":"2","author":"RK Keserwani","year":"2010","unstructured":"Keserwani RK, Kesharwani RK, Vyas N, Jain S, Raghuvanshi R, Sharma AK (2010a) Nutraceutical and functional food as future food: a review. Der Pharmacia Lettre 2010: 2(1):106\u2013116","journal-title":"Der Pharmacia Lettre"},{"issue":"1","key":"179_CR15","first-page":"59","volume":"1","author":"RK Keserwani","year":"2010","unstructured":"Keserwani RK, Kesharwani RK, Vyas N, Chadokar A (2010b) Nutritional supplements: an overview. Int J Curr Pharm Rev Res 1(1):59\u201375","journal-title":"Int J Curr Pharm Rev Res"},{"issue":"8","key":"179_CR16","first-page":"1060","volume":"101","author":"RK Kesharwani","year":"2011","unstructured":"Kesharwani RK, Misra K (2011) Prediction of binding site for curcuminoids at human topoisomerase II \u03b1 protein; an in silico approach. Curr Sci 101(8):1060\u20131064","journal-title":"Curr Sci"},{"key":"179_CR17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/0972-9062.117479","volume":"50","author":"RK Kesharwani","year":"2013","unstructured":"Kesharwani RK, Singh DV, Misra K (2013) Computation-based virtual screening for designing novel antimalarial drugs by targeting falcipain-III: a structure-based drug designing approach. J Vector Borne Dis 50:93\u2013102","journal-title":"J Vector Borne Dis"},{"key":"179_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s12010-015-1696-x","author":"RK Kesharwani","year":"2015","unstructured":"Kesharwani RK, Srivastava V, Singh P, Rizvi SI, Adeppa K, Misra K (2015) A novel approach for overcoming drug resistance in breast cancer chemotherapy by targeting new synthetic curcumin analogues against aldehyde dehydrogenase 1 (ALDH1A1) and glycogen synthase kinase-3 \u03b2 (GSK-3\u03b2). Appl Biochem Biotechnol. https:\/\/doi.org\/10.1007\/s12010-015-1696-x","journal-title":"Appl Biochem Biotechnol"},{"key":"179_CR38","unstructured":"Maestro (v7.0.113) (2005) A unified interface for all Schrodinger products, developed and marketed by Schrodinger, LLC. NY http:\/\/www.schrodinger.com . Accessed 5 July 2014"},{"issue":"6","key":"179_CR19","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1080\/14756360310001613085","volume":"Chem18","author":"C Mart\u00edn-Cordero","year":"2003","unstructured":"Mart\u00edn-Cordero C, L\u00f3pez-L\u00e1zaro M, G\u00e1lvez M, Ayuso MJ (2003) Curcumin as a DNA topoisomerase II poison. J Enzyme Inhib Med Chem18(6):505\u2013509","journal-title":"J Enzyme Inhib Med"},{"issue":"5","key":"179_CR20","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1159\/000079487","volume":"66","author":"M Martin-Richard","year":"2004","unstructured":"Martin-Richard M, Mu\u00f1oz M, Albanell J, Colomo L, Bellet M, Rey MJ, Tabernero J, Alonso C, Cardesa A, Gascon P, Fernandez PL (2004) Serial topoisomerase II expression in primary breast cancer and response to neoadjuvant anthracycline-based chemotherapy. Oncology 66(5):388\u2013394","journal-title":"Oncology"},{"key":"179_CR21","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1006\/jmbi.1994.1334","volume":"238","author":"IK McDonald","year":"1994","unstructured":"McDonald IK, Thornton JM (1994) Satisfying hydrogen bonding potential in proteins. JMB 238:777\u2013793","journal-title":"JMB"},{"issue":"11","key":"179_CR22","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.1093\/nar\/gkm335","volume":"35","author":"F Mueller-Planitz","year":"2007","unstructured":"Mueller-Planitz F, Herschlag D (2007) DNA topoisomerase II selects DNA cleavage sites based on reactivity rather than binding affinity. Nucleic Acids Res 35(11):3764\u20133773","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"179_CR23","first-page":"329","volume":"20","author":"P Poma","year":"2007","unstructured":"Poma P, Notarbartolo M, Labbozzetta M, Maurici A, Carina V, Alaimo A et al (2007) The antitumor activities of curcumin and of its isoxazole analogue are not affected by multiple gene expression changes in an MDR model of the MCF-7 breast cancer cell line: analysis of the possible molecular basis. Int J Mol Med 20(3):329\u2013335","journal-title":"Int J Mol Med"},{"issue":"3","key":"179_CR24","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1208\/s12248-009-9128-x","volume":"11","author":"J Ravindran","year":"2009","unstructured":"Ravindran J, Prasad S, Aggarwal BB (2009) Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS J 11(3):495\u2013510","journal-title":"AAPS J"},{"issue":"1","key":"179_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0304-3835(95)03827-J","volume":"94","author":"AJ Ruby","year":"1995","unstructured":"Ruby AJ, Kuttan G, Dinesh Babu K, Rajasekharan KN, Kuttan R (1995) Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett 94(1):79\u201383","journal-title":"Cancer Lett"},{"key":"179_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s13721-012-0021-7","volume":"2","author":"DB Singh","year":"2013","unstructured":"Singh DB, Gupta MK, Kesharwani RK, Misra K (2013) Comparative docking and ADMET study of some curcumin derivatives and herbal congeners targeting b-amyloid. Netw Model Anal Health Inform Bioinform (2013) 2:13\u201327. https:\/\/doi.org\/10.1007\/s13721-012-0021-7","journal-title":"Netw Model Anal Health Inform Bioinform"},{"issue":"4","key":"179_CR27","first-page":"286","volume":"5","author":"DV Singh","year":"2014","unstructured":"Singh DV, Agarwal S, Kesharwani RK, Misra K (2014) 3D QSAR and pharmacophore study of curcuminoids and curcumin analogs: interaction with thioredoxin reductase, interdisciplinary sciences. Comput Life Sci 5(4):286\u2013295","journal-title":"Comput Life Sci"},{"key":"179_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2014.12.007","author":"P Singh","year":"2015","unstructured":"Singh P, Kesharwani RK, Misra K, Rizvi SI (2015) The modulation of erythrocyte Na+\/K+-ATPase activity by curcumin. J Adv Res. https:\/\/doi.org\/10.1016\/j.jare.2014.12.007","journal-title":"J Adv Res"},{"issue":"23","key":"179_CR29","doi-asserted-by":"publisher","first-page":"6627","DOI":"10.1016\/j.bmcl.2009.10.023","volume":"19","author":"A Sun","year":"2009","unstructured":"Sun A, Lu YJ, Hu H, Shoji M, Liotta DC, Snyder JP (2009) Curcumin analog cytotoxicity against breast cancer cells: exploitation of a redox-dependent mechanism. Bioorg Med Chem Lett 19(23):6627\u20136631. https:\/\/doi.org\/10.1016\/j.bmcl.2009.10.023","journal-title":"Bioorg Med Chem Lett"},{"issue":"11","key":"179_CR30","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1021\/jm051197e","volume":"49","author":"R Thomsen","year":"2006","unstructured":"Thomsen R, Christensen MH (2006) MolDock: a new technique for high-accuracy molecular docking. J Med Chem 49(11):3315\u20133321","journal-title":"J Med Chem"},{"key":"179_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s40011-014-0405-9","author":"A Tripathi","year":"2014","unstructured":"Tripathi A, Singh DV, Kesharwani RK, Misra K (2014) P-Glycoprotein: a critical comparison of models depicting mechanism of drug efflux and role of modulators. Proc Natl Acad Sci India Sect B Biol. https:\/\/doi.org\/10.1007\/s40011-014-0405-9","journal-title":"Proc Natl Acad Sci India Sect B Biol"},{"issue":"6","key":"179_CR32","doi-asserted-by":"publisher","first-page":"233","DOI":"10.6026\/97320630004233","volume":"4","author":"J Upadhyay","year":"2009","unstructured":"Upadhyay J, Kesharwani RK, Misra K (2009) Comparative study of antioxidants as cancer preventives through inhibition of HIF-1 alpha activity. Bioinformation 4(6):233\u2013236","journal-title":"Bioinformation"},{"issue":"1","key":"179_CR33","first-page":"77","volume":"2","author":"J Upadhyaya","year":"2009","unstructured":"Upadhyaya J, Kesharwani RK, Misra K (2009) Metabolism, pharmacokinetics and bioavailability of ascorbic acid; synergistic effect with tocopherols and curcumin. J Comput Intell Bioinform 2(1):77\u201384","journal-title":"J Comput Intell Bioinform"},{"issue":"6","key":"179_CR34","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/nrm831","volume":"3","author":"JC Wang","year":"2002","unstructured":"Wang JC (2002) Cellular roles of DNA topoisomerases: a molecular perspective. Nat Rev Mol Cell Biol 3(6):430\u2013440","journal-title":"Nat Rev Mol Cell Biol"},{"key":"179_CR35","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/s0089400060498","volume":"6","author":"R Wang","year":"2000","unstructured":"Wang R, Gao Y, Lai L (2000) Ligbuilder: a multiple-purpose program for structure-based drug design. J Mol Model 6:498\u2013516","journal-title":"J Mol Model"},{"key":"179_CR36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1477-3163-5-14","volume":"5","author":"G Waris","year":"2006","unstructured":"Waris G, Ahsan H (2006) Reactive oxygen species: role in the development of cancer and various chronic conditions. J Carcinog 5:14","journal-title":"J Carcinog"},{"issue":"44","key":"179_CR37","doi-asserted-by":"publisher","first-page":"37041","DOI":"10.1074\/jbc.M506520200","volume":"280","author":"H Wei","year":"2005","unstructured":"Wei H, Ruthenburg AJ, Bechis SK, Verdine GL (2005) Nucleotide-dependent domain movement in the ATPase domain of a human type IIA DNA topoisomerase. J Biol Chem 280(44):37041\u201337047","journal-title":"J Biol Chem"}],"container-title":["Network Modeling Analysis in Health Informatics and Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13721-018-0179-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-018-0179-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-018-0179-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T11:27:37Z","timestamp":1720783657000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13721-018-0179-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,15]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["179"],"URL":"https:\/\/doi.org\/10.1007\/s13721-018-0179-8","relation":{},"ISSN":["2192-6662","2192-6670"],"issn-type":[{"value":"2192-6662","type":"print"},{"value":"2192-6670","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,15]]},"assertion":[{"value":"3 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Compliance with ethical standards"}},{"value":"The author confirms that this article content has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"15"}}